Biopharmaceuticals - GSK pays big for late-stage cancer drug

被引：0
|
作者：
Jarvis, Lisa
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2007年 / 85卷 / 01期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] Alcohol intake and late-stage promotion of breast cancer
    Stoll, BA
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (12) : 1653 - 1658
  • [42] COMMUNICATION IN LATE-STAGE CANCER: EXPLORING HOSPICE DECISIONS
    Waldrop, D.
    GERONTOLOGIST, 2012, 52 : 142 - 142
  • [43] Consensus molecular subtypes in late-stage colorectal cancer
    Bjerrum, A.
    Stannius, T. O.
    Belcaid, L.
    Rohrberg, K. S.
    Spanggaard, I.
    Hoejgaard, M.
    Nlelsen, F. C.
    Bagger, F. O.
    Qvortrup, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1318 - S1318
  • [44] Drug combination extends late-stage pancreatic cancer survival in Phase III clinical trial
    Patel, Jitesh
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (03) : 202 - 202
  • [45] Late-stage cancer detection in the USA is costing lives
    不详
    LANCET, 2010, 376 (9756): : 1873 - 1873
  • [46] Risk of late-stage breast cancer after a childbirth
    Wohlfahrt, J
    Andersen, PK
    Mouridsen, HT
    Melbye, M
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : 1079 - 1084
  • [47] Geographic Variation in Late-Stage Cervical Cancer Diagnosis
    Sokale, Itunu
    Thrift, Aaron
    Montealegre, Jane
    Adekanmbi, Victor
    Chido-Amajuoyi, Onyema
    Amuta, Ann
    Reitzel, Lorraine
    Oluyomi, Abiodun
    JAMA NETWORK OPEN, 2023, 6 (11) : E2343152
  • [48] Eribulin mesylate for the treatment of late-stage breast cancer
    Gourmelon, Carole
    Frenel, Jean Sebastien
    Campone, Mario
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2883 - 2890
  • [49] Drug combination extends late-stage pancreatic cancer survival in Phase III clinical trial
    Patel, Jitesh
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (03) : 248 - 248
  • [50] Drug combination extends late-stage pancreatic cancer survival in Phase III clinical trial
    Patel, Jitesh
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02): : 100 - 100
12345